• Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP
  • Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP
  • Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP
  • Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP
  • Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP
  • Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP

Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP

Application: Internal Medicine
Usage Mode: For oral administration
Suitable for: Elderly, Children, Adult
State: Solid
Shape: Tablet
Type: Western Medicines
Samples:
US$ 0/Piece 1 Piece(Min.Order)
| Request Sample
Customization:

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company

Basic Info.

Model NO.
AMC12020-01
Pharmaceutical Technology
Bp, USP or Cp
Shelf Life
3 Years
Registration Dossiers
Available
Transport Package
500mg, 10X10′s/Box
Specification
GMP
Trademark
MEDIPHARM/OEM
Origin
China
Production Capacity
1000ctns Per Month

Product Description

Product Description

Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP

Indications:
Griseofulvin is primarily indicated in conditions like Dermatophytic infections, Fungal infection, Parkinson's disease.
This drug is contraindicated in patients with porphyria, hepatocellular failure, and in individuals with a history of hypersensitivity to griseofulvin.
Adverse reactions of griseofulvin are uncommon. Nausea, diarrhea, headache, skin eruptions and photosensitivity are occasionally observed. Hepatotoxicity and neurological side effects may rarely occur.

Drug Interactions:
Griseofulvin can interact with blood thinners and birth control pills.
Precautions & Warning:
Caution should be exercised in patients with history of liver disease, porphyria, lupus, or history of alcohol abuse, any allergy, who are taking other medications, during pregnancy and breastfeeding.
Avoid exposure to sunlight.
Use in Pregnancy and Nursing Mothers:
Griseofulvin is assigned to pregnancy category C. Animal studies have revealed evidence of embryotoxicity and teratogenicity. There are no controlled data in human pregnancies; however, there are reports of congenital anomalies, including cases of conjoined twins in two women, as well as increased risk of spontaneous abortion. The manufacturer considers griseofulvin use to be contraindicated during pregnancy. There are no data on the excretion of griseofulvin into human milk.
Treatment/antidote in The Event of Overdose:
Treatment is symptomatic and supportive. There is no specific antidote for treatment of griseofulvin intoxication.
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.

 

Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMPMedipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMPMedipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP
Medipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMPMedipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMPMedipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMPMedipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMPMedipharm Griseofulvin Tablet 500mg 10X10′s/Box with GMP

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Management System Certification
ISO 9001, GMP, ISO 13485, FSC
Import & Export Mode
Have Own Export License